BPC-157 (Body Protection Compound-157), also written BPC 157 or BPC157, is a synthetic pentadecapeptide of fifteen amino acids, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), molecular formula CHNO, molecular weight 1419.53 g/mol, CAS 137525-51-0
For skin and dermatological research focused on a localized area, topical copper peptide dosing often achieves the research objective with lower total compound use because the peptide concentrates at the target site
Five years after treatment or remission is used as a conservative review window rather than a proven biological cutoff
So let me give you a clear, honest, evidence-based look at what we actually know, what remains uncertain, and what I tell my patients when they ask about it
The FDA usually relies on clinical trials when it is looking at adding a substance to the 503A bulks list, which determines what ingredients compounding pharmacies can use in mixing drugs
Misuse of these products is strictly prohibited